Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/1999
05/27/1999WO1999026070A2 Method for automatic implementation of chemical or biological methods
05/27/1999WO1999026069A1 Improvements in or relating to detection of molecules in samples
05/27/1999WO1999025877A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999WO1999025876A1 Expression cloning processes for the discovery, characterization and isolation of genes encoding polypeptides with a predetermined property
05/27/1999WO1999025875A1 Production of a lampbrush chromosome
05/27/1999WO1999025873A1 METHOD FOR UNBIASED mRNA AMPLIFICATION
05/27/1999WO1999025872A1 Heterozygote screening process
05/27/1999WO1999025870A1 Method for identifying escherichia coli strain dsm 6601
05/27/1999WO1999025869A1 Dna sequences of genes from fimbriae d'escherichia coli strain dsm 6601
05/27/1999WO1999025866A1 Tetracycline assay method
05/27/1999WO1999025865A1 Regulation of fungal gene expression
05/27/1999WO1999025863A1 Transfection and transfer of male germ cells for generation of transgenic species
05/27/1999WO1999025862A2 Chimeric viral packaging signal without gag gene sequences
05/27/1999WO1999025861A2 Adenovirus vectors and method for reducing homologous recombination phenomena
05/27/1999WO1999025860A1 Vector for tissue-specific replication and gene expression
05/27/1999WO1999025859A1 Alphavirus vectors
05/27/1999WO1999025858A1 Alphavirus vectors for paramyxovirus vaccines
05/27/1999WO1999025857A2 Transgenic models of inflammatory disease
05/27/1999WO1999025856A1 System and method for regulation of gene expression
05/27/1999WO1999025855A1 Mobilization of viral genomes from t-dna using site-specific recombination systems
05/27/1999WO1999025854A1 A method for directional stable transformation of eukaryotic cells
05/27/1999WO1999025853A1 Targeted manipulation of herbicide-resistance genes in plants
05/27/1999WO1999025852A1 Stress resistance gene
05/27/1999WO1999025851A1 VARIANT loxP SEQUENCES AND APPLICATION OF THE SAME
05/27/1999WO1999025849A1 Single-chain bifunctional glycoprotein hormones
05/27/1999WO1999025848A1 A polynucleotide encoding cp70 cold active protease
05/27/1999WO1999025847A2 Cellulase produced by actinomycetes and method of producing same
05/27/1999WO1999025846A2 Cellulase produced by actinomycetes and method for producing same
05/27/1999WO1999025845A1 Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same
05/27/1999WO1999025844A1 Mammalian cell death preventing kinase, dpk
05/27/1999WO1999025843A2 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999WO1999025842A1 Chimera gene having a light dependent promoter providing tolerance to hppd inhibitors
05/27/1999WO1999025841A1 Novel nucleic acid sequence encoding flp recombinase
05/27/1999WO1999025840A1 A novel method for the integration of foreign dna into eukaryoticgenomes
05/27/1999WO1999025839A1 Polypeptides having uroporphyrinogen decarboxylase activity and nucleic acids encoding same
05/27/1999WO1999025838A1 Compositions and methods to prevent turkey enteritis
05/27/1999WO1999025837A2 Method for producing virus-like particles on the basis of polyoma viruses
05/27/1999WO1999025836A1 Attaching substances to micro-organisms
05/27/1999WO1999025835A1 Improvements relating to protein accumulation
05/27/1999WO1999025834A1 Dna19355 polypeptide, a tumor necrosis factor homolog
05/27/1999WO1999025833A1 Methods for modulating nerve cell function
05/27/1999WO1999025832A1 Toso
05/27/1999WO1999025831A2 Slit polypeptide and method of modulation of robo with ligands
05/27/1999WO1999025830A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999WO1999025829A2 Cdk2 protein and cdk2 protein complexes
05/27/1999WO1999025828A1 A human 2-19 protein homologue, z219c
05/27/1999WO1999025827A1 Neuralized protein, polynucleotide encoding the same, and antibody recognizing the same
05/27/1999WO1999025826A1 Method and kit for determining severe inflammatory reactions to mosquito bites
05/27/1999WO1999025825A2 EXTENDED cDNAs FOR SECRETED PROTEINS
05/27/1999WO1999025824A1 cDNA SEQUENCE CODING FOR A MUTATED LEPTIN AND APPLICATIONS
05/27/1999WO1999025823A2 Recombinant allergen with reduced enzymatic activity
05/27/1999WO1999025822A1 The exostosin-4 gene
05/27/1999WO1999025821A1 Compositions and methods for genetic modification of plants
05/27/1999WO1999025819A2 Antisense oligonucleotides against tenascin for treating vitiligo
05/27/1999WO1999025818A1 Method of identifying binding site domains that retain the capacity of binding to an epitope
05/27/1999WO1999025817A2 Tc1-based transposon vectors
05/27/1999WO1999025815A2 Nucleic acids involved in the responder phenotype and applications thereof
05/27/1999WO1999025814A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy
05/27/1999WO1999025810A1 Transgenic animal models for human bladder cancer
05/27/1999WO1999025739A1 Variable region fusion peptides that form effector complexes in the presence of antigen
05/27/1999WO1999025735A1 Chimeric pre-activated transcription factors
05/27/1999WO1999025734A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS
05/27/1999WO1999025724A2 Oligonucleotide synthesis using high boiling point solvents
05/27/1999WO1999025387A1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype
05/27/1999WO1999025380A2 Methods and compositions for the treatment of psoriasis
05/27/1999WO1999025379A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999WO1999025378A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999WO1999025377A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
05/27/1999WO1999025324A1 Administering active substances by using the capsid produced out of the polyoma virus vp1 protein
05/27/1999WO1999025320A1 Targeted liposome gene delivery
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999014330A8 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
05/27/1999WO1999013908A9 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
05/27/1999WO1999013092A9 Enhancement of mucosal antibody responses by interleukin-6
05/27/1999WO1999013089A8 Nucleic acid sequences to reduce another dehiscence
05/27/1999WO1999013084A9 Group a streptococcal vaccines
05/27/1999WO1999013075A3 Human genes regulated by human cytomegalovirus and interferon
05/27/1999WO1999012964A3 Kay - a novel immune system protein
05/27/1999WO1999012961A8 Estrogen receptor
05/27/1999WO1999012949A3 AMINO ACID SEQUENCES AND METHOD FOR ISOLATING BACTERIES FROM THE TYPE GENUS $i(PSEUDOMONAS)
05/27/1999WO1999011799A3 Human aminopeptidase p gene
05/27/1999WO1999011780A3 Conductine protein and a related agent for diagnosing and treating tumor illnesses
05/27/1999WO1999011758A3 Cultures of human cns neural stem cells
05/27/1999WO1999010480A3 New tissue-specific calpaines, their production and their use
05/27/1999WO1999007886A3 Group of nucleic acid molecules for salmonella detection, nucleic acids, kit and use
05/27/1999WO1999006554A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES
05/27/1999WO1999006553B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES
05/27/1999WO1999005283A3 Biosynthesis genes and transfer of 6-desoxy-hexoses in saccharopolyspora erythraea and in streptomyces antibioticus and their use
05/27/1999WO1999005270A3 Crustacean antimicrobial peptides, called penaiedines
05/27/1999WO1999003976A3 Method of treating leukocytes, leukocyte compositions and methods of use thereof
05/27/1999WO1999000152A3 Biosynthetic transplant and method for the production thereof
05/27/1999WO1998055495A3 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
05/27/1999WO1998049292A3 Polypeptides associated with activator receptors and their biological applications
05/27/1999DE19751242A1 New DNA encoding fimbrial subunits of Escherichia coli DSM 6601 used as source of primers
05/27/1999DE19750702A1 Antisense oligonucleotides that bind to sequences encoding human tenascin for treating depigmentation, cancer, inflammation and cardiovascular disease
05/27/1999DE19750354A1 Covering an inductor molecule with a viral capsid, for more efficient transfection of cells
05/27/1999CA2739604A1 Targeted liposome gene delivery
05/27/1999CA2320399A1 A human 2-19 protein homologue, z219c
05/27/1999CA2316189A1 System and method for regulation of gene expression
05/27/1999CA2311526A1 Heterozygote screening process
1 ... 3396 3397 3398 3399 3400 3401 3402 3403 3404 3405 3406 3407 3408 3409 3410 3411 3412 3413 3414 3415 3416 ... 4023